Jeff Lee

Jeff Lee has extensive experience in the biopharmaceutical industry. Jeff is currently serving as the Vice President of Site Quality Operations at KBI Biopharma since July 2021. Prior to this, they worked at Novartis as the Senior Director of Site Quality Head from April 2019 to July 2021. At Novartis, they were responsible for quality assurance, quality control, and quality systems for a gene therapy manufacturing site. Before Novartis, Jeff held positions at AstraZeneca, where they served as the Quality Site Head from May 2018 to March 2019 and as the Director of Quality Assurance from September 2016 to May 2018. Jeff also worked at KBI Biopharma, where they had roles as the VP of Quality - Site Quality Head from July 2015 to September 2016 and as the Director of Quality - Site Quality Head from June 2014 to June 2015. Prior to these roles, Jeff worked at Amgen as a Senior Manager of Quality Assurance from April 2010 to June 2014, and previously as a Senior Manager of Manufacturing from an unspecified start date to April 2010.

From 1992 to 1995, Jeff Lee attended The University of New Mexico, but did not obtain a degree or specialize in any specific field of study.